Brief: Percheron Therapeutics Says A$13 Mln Institutional Placement At A$0.08 Per New Share
Oct 18 (Reuters) - Percheron Therapeutics Ltd PER.AX :
* A$13.0 MILLION INSTITUTIONAL PLACEMENT AT A PRICE OF
A$0.08 PER
NEW SHARE
Further company coverage: PER.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Percheron Therapeutics
See all newsBrief: Invion Announces Preclinical Research Collaboration With Percheron Therapeutics
Brief: Percheron Therapeutics Receives Firm Commitments For A$2.3 Million Institutional Placement
Brief: Percheron Therapeutics Appoints Ambrosini as Interim Board Member During CEO Transition Period
Brief: Percheron Therapeutics Says Vanderbilt Health To Conduct Clinical Trial Of Hmbd-002 In Acute Myeloid Leukaemia
Brief: Percheron Therapeutics Says James Garner To Step Down As CEO And Managing Director